BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 18508633)

  • 21. Cancer cytogenetics and molecular genetics: detection and therapeutic strategy.
    Sandberg AA; Chen Z
    In Vivo; 1994; 8(5):807-18. PubMed ID: 7727729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases.
    Morel P; Hebbar M; Lai JL; Duhamel A; Preudhomme C; Wattel E; Bauters F; Fenaux P
    Leukemia; 1993 Sep; 7(9):1315-23. PubMed ID: 8371581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Common fragile sites associated with the breakpoints of chromosomal aberrations in hematologic neoplasms.
    Gümüş G; Sunguroğlu A; Tükün A; Sayin DB; Bökesoy I
    Cancer Genet Cytogenet; 2002 Mar; 133(2):168-71. PubMed ID: 11943347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [FISH diagnostics].
    Sápi Z; Bodó M
    Magy Onkol; 2002; 46(1):25-32. PubMed ID: 12050679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnosis and prognosis in myelodysplastic syndromes. The impact of cytogenetics].
    Mecucci C
    Recenti Prog Med; 2014 Mar; 105(3):110-4. PubMed ID: 24675452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metaphase harvest and cytogenetic analysis of malignant hematological specimens.
    Dal Cin P; McLaughlin C
    Curr Protoc Hum Genet; 2012 Apr; Chapter 10():Unit 10.2.1-15. PubMed ID: 22470141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cytogenetics of myelodysplastic syndromes].
    Laï JL; Fenaux P
    Pathol Biol (Paris); 1997 Sep; 45(7):550-5. PubMed ID: 9404478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular cytogenetic profiling of complex karyotypes in primary myelodysplastic syndromes and acute myeloid leukemia.
    Trost D; Hildebrandt B; Beier M; Müller N; Germing U; Royer-Pokora B
    Cancer Genet Cytogenet; 2006 Feb; 165(1):51-63. PubMed ID: 16490597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Novel diagnostic procedures for hematologic malignancies on the basis of genomic alterations].
    Taniwaki M
    Rinsho Ketsueki; 2001 May; 42(5):352-5. PubMed ID: 11452449
    [No Abstract]   [Full Text] [Related]  

  • 30. Inherited thrombocytopenia and platelet disorders with germline predisposition to myeloid neoplasia.
    Galera P; Dulau-Florea A; Calvo KR
    Int J Lab Hematol; 2019 May; 41 Suppl 1():131-141. PubMed ID: 31069978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of new technologies in the detection of balanced translocations in hematologic disorders.
    Shaffer LG; Schultz RA; Ballif BC
    Curr Opin Genet Dev; 2012 Jun; 22(3):264-71. PubMed ID: 22336526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrent Cytogenetic Abnormalities in Acute Myeloid Leukemia.
    Yang JJ; Park TS; Wan TS
    Methods Mol Biol; 2017; 1541():223-245. PubMed ID: 27910027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The unexplored 5q13 locus: a role in hematopoietic malignancies.
    Castro PD; Fairman J; Nagarajan L
    Leuk Lymphoma; 1998 Aug; 30(5-6):443-8. PubMed ID: 9711906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of B-cell neoplasias by spectral karyotyping (SKY).
    Hilgenfeld E; Padilla-Nash H; Schröck E; Ried T
    Curr Top Microbiol Immunol; 1999; 246():169-74. PubMed ID: 10396053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytogenetics in the investigation of haematological disorders.
    Heim S
    Baillieres Clin Haematol; 1990 Oct; 3(4):921-48. PubMed ID: 2271796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Significance of chromosomal abnormalities in solid tumors of humans].
    Limon J; Mitelman F
    Pol J Pathol; 1994; 45(1):1-15. PubMed ID: 8177615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A case of treatment-related myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemotherapy with autologous stem cell transplantation for non-Hodgkin's lymphoma.
    Jang GD; Kim SW; Suh CW; Kim EK; Bahng HS; Jeong YH; Park IG; Kim WK; Kim SH; Suh EJ; Park CJ; Ji HS; Lee JS
    J Korean Med Sci; 2002 Aug; 17(4):555-9. PubMed ID: 12172056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trisomy 14 is a non-random karyotypic abnormality associated with myeloid malignancies.
    Toze CL; Barnett MJ; Naiman SC; Horsman DE
    Br J Haematol; 1997 Jul; 98(1):177-85. PubMed ID: 9233582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predominance of chromosome 5 deletions in myeloid neoplasia associated with solid tumors managed by surgical excision.
    List AF; Shamdas GJ; Veomett I; Spier C; Morgan R; Sandberg AA
    Cancer Genet Cytogenet; 1992 Feb; 58(2):125-9. PubMed ID: 1551074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of cytogenetics in neoplastic diseases.
    Sandberg AA
    Crit Rev Clin Lab Sci; 1985; 22(3):219-74. PubMed ID: 3899509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.